Opinion

Video

Looking Ahead: Future Landscape for Treating OFF Time and Dyskinesia

Author(s):

Daniel E. Kremens, MD, JD

An expert discusses D1 receptor agonists that reduce negative symptoms and the increasing availability of recent and upcoming PUMP options for Parkinson disease treatment.

Related Videos
1 expert is featured in this series.
James Beck, PhD
Related Content
Rajesh Pahwa, MD (Credit: University of Kansas Medical Center)
April 8th 2025

IPX203 Boosts “Good ON” Time in Parkinson Disease, Especially in Patients on Lower Dopamine Agonist Doses

Isabella Ciccone, MPH
Multisymptomatic Care in Parkinson's Disease
September 4th 2024

Multisymptomatic Care in Parkinson's Disease

Stuart H. Isaacson, MD, FAAN Rajesh Pahwa, MD Jennifer G. Goldman, MD, MS
Viktoria Azoidou, PhD (Credit: Charco Neurotech)
April 3rd 2025

Vibrotactile Stimulation Device Shows Promise in Addressing Gait Issues in Parkinson Disease

Isabella Ciccone, MPH
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
April 9th 2024

Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease

Anne Marie Morse, DO, FAASM NeurologyLive® Staff
NeurologyLive® Brain Games: March 9, 2025
March 9th 2025

NeurologyLive® Brain Games: March 9, 2025

Marco Meglio
FDA Approves Medtronic’s Adaptive Deep Brain Stimulation for Parkinson Disease
February 24th 2025

FDA Approves Medtronic’s Adaptive Deep Brain Stimulation for Parkinson Disease

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.